Search research articles
Contact Us
Filters
Showing results (11-20 of 83) with videos related to
Page
of 9
Sort By:
Expert Opinion on Pharmacotherapy
|
December 7, 2018
Choosing an ideal pharmacotherapeutic strategy for dyslipidemia in children
Dragana Nikolic, Andreea Corina, Peter P Toth, et al.
Cancers
|
August 12, 2023
Cellular Adaptation Takes Advantage of Atavistic Regression Programs during Carcinogenesis
Davide Gnocchi, Dragana Nikolic, Rosa Rita Paparella, et al.
Atherosclerosis
|
December 3, 2014
ETC-1002: a future option for lipid disorders?
Dragana Nikolic, Dimitri P Mikhailidis, Michael H Davidson, et al.
Angiology
|
July 20, 2014
Nutraceuticals in lipid-lowering treatment: a narrative review on the role of chitosan
Angelo Maria Patti, Niki Katsiki, Dragana Nikolic, et al.
Expert Opinion on Pharmacotherapy
|
September 10, 2013
Emerging approaches for the treatment of hypertriglyceridemia
Manfredi Rizzo, Pablo Perez-Martinez, Dragana Nikolic, et al.
Pharmacology & Therapeutics
|
November 21, 2016
Intensive LDL-cholesterol lowering therapy and neurocognitive function
Maciej Banach, Manfredi Rizzo, Dragana Nikolic, et al.
Expert Opinion on Investigational Drugs
|
September 15, 2015
An evaluation of RVX-208 for the treatment of atherosclerosis
Dragana Nikolic, Manfredi Rizzo, Dimitri P Mikhailidis, et al.
Aquaculture Science and Management
|
August 25, 2025
Precision farming in aquaculture: assessing gill health in Atlantic salmon (<i>Salmo salar</i>) using a non-invasive, AI-driven behavioural monitoring approach in commercial farms
Meredith Burke, Dragana Nikolic, Pieter Fabry, et al.
Current Pharmaceutical Design
|
January 16, 2013
The role of fibrate treatment in dyslipidemia: an overview
Niki Katsiki, Dragana Nikolic, Giuseppe Montalto, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism
|
May 21, 2014
Should low high-density lipoprotein cholesterol (HDL-C) be treated?
Peter P Toth, Marcin Barylski, Dragana Nikolic, et al.
Page
of 9
Search research articles
Search
Showing results (11-20 of 83) with videos related to
Sort By:
Page
of 9
Expert Opinion on Pharmacotherapy
|
December 7, 2018
Choosing an ideal pharmacotherapeutic strategy for dyslipidemia in children
Dragana Nikolic, Andreea Corina, Peter P Toth, et al.
Cancers
|
August 12, 2023
Cellular Adaptation Takes Advantage of Atavistic Regression Programs during Carcinogenesis
Davide Gnocchi, Dragana Nikolic, Rosa Rita Paparella, et al.
Atherosclerosis
|
December 3, 2014
ETC-1002: a future option for lipid disorders?
Dragana Nikolic, Dimitri P Mikhailidis, Michael H Davidson, et al.
Angiology
|
July 20, 2014
Nutraceuticals in lipid-lowering treatment: a narrative review on the role of chitosan
Angelo Maria Patti, Niki Katsiki, Dragana Nikolic, et al.
Expert Opinion on Pharmacotherapy
|
September 10, 2013
Emerging approaches for the treatment of hypertriglyceridemia
Manfredi Rizzo, Pablo Perez-Martinez, Dragana Nikolic, et al.
Pharmacology & Therapeutics
|
November 21, 2016
Intensive LDL-cholesterol lowering therapy and neurocognitive function
Maciej Banach, Manfredi Rizzo, Dragana Nikolic, et al.
Expert Opinion on Investigational Drugs
|
September 15, 2015
An evaluation of RVX-208 for the treatment of atherosclerosis
Dragana Nikolic, Manfredi Rizzo, Dimitri P Mikhailidis, et al.
Aquaculture Science and Management
|
August 25, 2025
Precision farming in aquaculture: assessing gill health in Atlantic salmon (<i>Salmo salar</i>) using a non-invasive, AI-driven behavioural monitoring approach in commercial farms
Meredith Burke, Dragana Nikolic, Pieter Fabry, et al.
Current Pharmaceutical Design
|
January 16, 2013
The role of fibrate treatment in dyslipidemia: an overview
Niki Katsiki, Dragana Nikolic, Giuseppe Montalto, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism
|
May 21, 2014
Should low high-density lipoprotein cholesterol (HDL-C) be treated?
Peter P Toth, Marcin Barylski, Dragana Nikolic, et al.
Page
of 9